Mogrifiy completes Series A financing round
Cell reprogramming specialist Mogrify Ltd has announced the second closing of its Series A financing of $17m, bringing the total raised to $33m in this round.
COVID-19 vaccine for poor countries
Moderna Inc. has signed a COVID-19 vaccine supply agreement with vaccination alliance Gavi.
ADCendo ApS raises 51m in Series A financing
Danish ADCendo ApS will use the funds from a Series A investment to advance Antibody-Drug Conjugates (ADCs) entering cancer cells through endocytic receptors.
DNA Script bags DARPA funding
DNA Script will receive a $5m DARPA grant as part of the agency’s Nucleic Acids On-Demand World-Wide Program to prevent the next viral pandemic.
First malaria vaccine meets WHO efficacy criteria
Researchers at Novavax and from the University of Oxford reported an efficacy of 77% of their malaria vaccine, R21/Matrix-M from a Phase II trials in Burkina Faso.
European COVID-19 antibody enters Phase III testing
GSK’s and Vir Therapeutics COVID-19 antibody treatment VIR-7831 has entered Phase III testing within the UKs COVID-19 drug testing platform, AGILE
J&J starts European COVID-19 vaccine roll-out
After a positive re-evaluation of J&Js COVID-19 vaccine by the European Medicines Agency (EMA), J&J has re-started to ship 55 million doses to the EU.
Endeavour Medtech Growth II LP closes at $375m
Endeavour Vision has announced the closing of its Heathtech fund Endeavour Medtech Growth II (EMG II) LP at US$375 million in capital commitments.
Record year for Swiss biotech industry
The Swiss biotech industry experienced a record investment in the pandemic year 2020, according to the new Swiss Biotech Report.
